Stockreport

Spruce Biosciences GAAP EPS of -$50.83 misses by $29.59 [Seeking Alpha]

Spruce Biosciences, Inc.  (SPRB) 
PDF Cash and cash equivalents as of December 31, 2025 were $48.9 million, which excludes the receipt of $15.0 million in gross proceeds under the loan facility with Avenue [Read more]